Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Study Points to Unexplored Realm of Protein Biology, Drug Targets

June 24, 2015 1:07 pm | by The Scripps Research Institute | News | Comments

Scientists at The Scripps Research Institute (TSRI) have devised a powerful set of chemical methods for exploring the biology of proteins. Read more...


AbbVie Announces New Phase3b Results for Liver Cirrhosis

June 24, 2015 12:58 pm | News | Comments

AbbVie, a global biopharmaceutical company, today announced TURQUOISE-III study results demonstrating 100 percent (n=60/60) sustained virologic response at 12 weeks post-treatment (SVR12) in genotype 1b (GT1b) chronic hepatitis C virus (HCV) infected adult patients with compensated liver cirrhosis. Read more...


Researchers ID Best Source of Stem Cells to Block Diabetic Blindness

June 24, 2015 12:52 pm | by UVA | News | Comments

University of Virginia School of Medicine researchers have taken a significant step forward in their efforts to use stem cells to block vision loss caused by diabetic retinopathy, a condition that affects millions of people with diabetes. Read more...


For Vitiligo Patient, Arthritis Drug Restores Skin Color

June 24, 2015 12:41 pm | by Yale University | News | Comments

A medication for treating rheumatoid arthritis has restored skin color in a patient suffering from vitiligo, according to dermatologists at Yale School of Medicine. The disfiguring condition is best known as the disease that plagued late pop star Michael Jackson. Read more...


Nanowire Implants Offer Remote-Controlled Drug Delivery

June 24, 2015 12:34 pm | by Seth Augenstein, Digital Reporter | News | Comments

A team of researchers has created a new implantable drug-delivery system using nanowires that can be wirelessly controlled. Read more...


Teens Invent Condom that Glows to Show STDs

June 24, 2015 11:12 am | by Seth Augenstein, Digital Reporter | News | Comments

A group of teenage inventors in the United Kingdom has invented a condom that changes colors to warn of STDs, according to multiple reports. Read more..


Medication May Stop Drug and Alcohol Addiction

June 24, 2015 8:55 am | by University of Texas at Austin | News | Comments

Researchers at The University of Texas at Austin have successfully stopped cocaine and alcohol addiction in experiments using a drug already approved by the U.S. Food and Drug Administration (FDA) to treat high blood pressure. If the treatment is proven effective in humans, it would be the first of its kind—one that could help prevent relapses by erasing the unconscious memories that underlie addiction. Read more...


‘High-Normal’ Blood Pressure in Young Adults Spells Risk of Heart Failure in Later Life

June 24, 2015 8:55 am | by Johns Hopkins University | News | Comments

Mild elevations in blood pressure considered to be in the upper range of normal during young adulthood can lead to subclinical heart damage by middle age — a condition that sets the stage for full-blown heart failure, according to findings of a federally funded study led by scientists at Johns Hopkins. Read more...


Model Could Help Counteract Poisoning from Popular Painkiller

June 24, 2015 8:55 am | by Duke University | News | Comments

New research could help reverse deadly side effects caused by excessive doses of the drug acetaminophen, the major ingredient in Tylenol and many other over-the-counter and prescription medicines. Read more...


Medtronic Announces FDA Approval for New TAVR System

June 24, 2015 8:54 am | News | Comments

This is the first-and-only recapturable and repositionable device available in the U.S. Read more...


FDA Approves Eisai's Antiepileptic Agent Fycompa

June 24, 2015 8:46 am | News | Comments

It will be used as an adjunctive treatment for primary generalized tonic-clonic seizures. Read more...


BMS Will Win Big with Melanoma Combination Immunotherapy

June 24, 2015 8:39 am | by Fenix Leung, DPhil, Oncology and Hematology Analyst, GlobalData | Articles | Comments

Data presented at the recent American Society of Clinical Oncology Annual Meeting 2015 by Bristol-Myers Squibb suggests that its Opdivo/Yervoy combination of immunotherapies to treat metastatic melanoma will shape the therapeutic landscape once it is approved. Read more...  


Merck Manual Now Online Only

June 23, 2015 1:43 pm | by Seth Augenstein, Digital Reporter | News | Comments

The book has been a go-to for doctors, patients and especially hypochondriacs for more than a century. Its first edition appeared in an era when rabies was treated with asparagus and acupuncture – and strychnine was considered a valid treatment for impotence. Read more...


Viagra Does Something Very Important—But It Is Unlikely to Cause Melanoma, Researchers Conclude

June 23, 2015 1:08 pm | by New York University School of Medicine | News | Comments

A rigorous analysis of more than 20,000 medical records concludes that erectile dysfunction drugs, such as Viagra, are not a cause of melanoma, an often deadly form of skin cancer, despite the higher risk for the disease among users of these drugs. Read more...


Study: Scant Evidence That Medical Pot Helps Many Illnesses

June 23, 2015 1:01 pm | by By Lindsey Tanner, AP Medical Writer | News | Comments

Medical marijuana has not been proven to work for many illnesses that state laws have approved it for, according to the first comprehensive analysis of research on its potential benefits. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.